Image of William Huynh

William Huynh

Senior U.S. Antitrust & Foreign Investment Associate, New York

Overview

Professional experience

Education and qualifications

Published works

Overview

Will advises on U.S. merger control in international M&A transactions. Will also counsels clients on cartel and other antitrust conduct. Prior to joining Linklaters, Will was an attorney at the U.S. Federal Trade Commission, where he investigated mergers in a variety of industries, including pharmaceutical manufacturing and distribution, medical devices, and technology.

He counsels clients in pre-signing phases as well as representing clients before the U.S. Federal Trade Commission and the Department of Justice.

Work highlights
  • Bayer AG: advising on approximately $8bn divestiture of its animal health business to Elanco Animal Health Incorporated.
  • Linde AG: advising on its approximately $70bn global business combination with Praxair Inc.
  • Dr. Reddy’s Laboratories Ltd.: advising on its approximately $350m acquisition of Teva/Allergan divestiture products.

Professional experience

Will has been an associate at Linklaters since 2015. Prior to joining the firm, Will was an a attorney at Federal Trade Commission in Washington D.C.

Education and qualifications

Will received his Juris Doctorate in 2011 from University of Virginia School of Law. Prior to that, in 2005, he obtained his Bachelor of Arts from Cornell University.

Published works

Co-author (with Douglas Tween), “Antitrust: How to navigate a perilous but underappreciated compliance risk area”, Concurrences Nº 1-2020, Feb 2020